Increased expression of CXCR4 and integrin αM in hypoxia- preconditioned cells contributes to improved cell retention and angiogenic potency

Journal of Cellular Physiology

Volumn 220, Issue 2, 2009, Pages 508-514

  Kubo, Masayuki ^a   Li, Tao Sheng ^a   Kamota, Takahiro ^a   Ohshima, Mako ^a   Qin, Shu Lan ^a   Hamano, Kimikazu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; CHEMOKINE RECEPTOR CXCR4; INTERCELLULAR ADHESION MOLECULE 1; STROMAL CELL DERIVED FACTOR 1; CD11B ANTIGEN; CXCR4 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CELL ADHESION; CELL CULTURE; CONDITIONING; CONTROLLED STUDY; FLOW CYTOMETRY; HINDLIMB; HYPOXIA; IMMUNOHISTOCHEMISTRY; IMPLANTATION; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL HYPOXIA; CELL TRANSPLANTATION; CHEMOTAXIS; GENETICS; ISCHEMIC PRECONDITIONING; METABOLISM; MICROARRAY ANALYSIS; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; ANTIGENS, CD11B; CELL HYPOXIA; CELL TRANSPLANTATION; CELLS, CULTURED; CHEMOKINE CXCL12; CHEMOTAXIS; HINDLIMB; INTERCELLULAR ADHESION MOLECULE-1; ISCHEMIC PRECONDITIONING; MALE; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CXCR4; REGIONAL BLOOD FLOW;

EID: 67649378992     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21803     Document Type: Article

References (26)

1. Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B, Eckey T, Henze E, Zeiher AM, Dimmeler S. 2003. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107:2134-2139.
2. Akita T, Murohara T, Ikeda H, Sasaki K, Shimada T, Egami K, Imaizumi T. 2003. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest 83:65-73.
3. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864.
4. Chavakis E, Aicher A, Heeschen C, Sasaki K, Kaiser R, El Makhfi N, Urbich C, Peters T, Scharffetter-Kochanek K, Zeiher AM, Chavakis T, Dimmeler S. 2005. Role of b2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 201:63-72.
5. Cowden Dahl KD, Robertson SE, Weaver VM, Simon MC. 2005. Hypoxia-inducible factor regulates av b3 integrin cell surface expression. Mol Biol Cell 16:1901-1912.
6. Danen EH, Sonnenberg A. 2003. Integrins in regulation of tissue development and function. J Pathol 201:632-641.
7. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M. 2004. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104:3472-3482.
8. Docheva D, Popov C, Mutschler W, Schieker M. 2007. Human mesenchymal stem cells in contact with their environment: Surface characteristics and the integrin system. J Cell Mol Med 11:21-38.
9. Esato K, Hamano K, Li TS, Furutani A, Seyama A, Takenaka H, Zempo N. 2002. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant 11:747-752.
10. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, Miura T, Matsuzaki M, Esato K. 2001. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: Clinical trial and preliminary results. Jpn Circ J 65:845-847.
11. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B, Hattori K, Zhang F, Hicklin DJ, Wu Y, Zhu Z, Dunn A, Salari H, Werb Z, Hackett NR, Crystal RG, Lyden D, Rafii S. 2006. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12:557-567.
12. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D,Wang J, Homma S, Edwards NM, Itescu S. 2001. Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436.
13. Kong T, Eltzschig HK, Karhausen J, Colgan SP, Shelley CS. 2004. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of b2 integrin gene expression. Proc Natl Acad Sci USA 101:10440-10445.
14. Kubo M, Li TS, Suzuki R, Ohshima M, Qin SL, Hamano K. 2007. Short-term pretreatmentwith low-dose hydrogen peroxide enhances the efficacy of bone marrow cells for therapeutic angiogenesis. Am J Physiol Heart Circ Physiol 292:H2582-H2588.
15. Kubo M, Li TS, Suzuki R, Shirasawa B, Morikage N, Ohshima M, Qin SL, Hamano K. 2008. Hypoxic preconditioning increases the survival and angiogenic potency of peripheral blood mononuclear cells via oxidative stress resistance. Am J Physiol Heart Circ Physiol 294:H590-595.
16. Li TS, Hamano K, Suzuki K, Ito H, ZempoN, MatsuzakiM. 2002. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol 283:H468-H473.
17. + stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol 285:H931-H937.
18. Li TS, Ito H, Hayashi M, Furutani A, Matsuzaki M, Hamano K. 2005. Cellular expression of integrin-b1 is of critical importance for inducing therapeutic angiogenesis by cell implantation. Cardiovasc Res 65:64-72.
19. Perin EC, DohmannHF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI,Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. 2003. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107:2294-2302.
20. Petit I, Jin D, Rafii S. 2007. The SDF-1-CXCR4 signaling pathway: A molecular hub modulating neo-angiogenesis. Trends Immunol 28:299-307.
21. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W. 2003. Chemokine receptor CXCR4downregulated by vonHippel-Lindau tumour suppressor pVHL. Nature 425:307-311.
22. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, KishimotoY, YoshimotoK,AkashiH, ShimadaK, Iwasaka T, Imaizumi T. 2002. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 360:427-435.
23. Uemura R, Xu M, Ahmad N, Ashraf M. 2006. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98:1414-1421.
24. Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D, Hatzopoulos AK. 2003. Multistep nature of microvascular recruitment of ex vivoexpanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 197:1755-1765.
25. WuY, Ip JE, Huang J, Zhang L, Matsushita K, Liew CC, Pratt RE, Dzau VJ. 2006. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res 99:315-322.
26. Yoon CH, Hur J, Oh IY, Park KW, Kim TY, Shin JH, Kim JH, Lee CS, Chung JK, Park YB, Kim HS. 2006. Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 26:1066-1072.